HomeNDC LookupRxCUI directory › RxCUI 349201

Valsartan 160 MG Oral Tablet — RxCUI 349201

RxNorm drug concept · Semantic clinical drug
RxCUI 349201 Semantic clinical drug · SCD ● Current RxNorm concept 111 FDA products 312 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI349201
Official nameValsartan 160 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped111
Package NDCs mapped312
Reported Medicaid activity (SDUD)609,688 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Valsartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Valsartan is a blood pressure-lowering medication. It's most commonly used to treat high blood pressure, but it's also prescribed for heart failure and to reduce the risk of dying...
  • Yes — valsartan tablets can be taken with or without food, so take it whichever way works best for you. Just try to take it at the same time each day to keep your blood levels stea...
  • Can I take valsartan with or without food?
  • The most common ones are headache, dizziness, tiredness, and stomach pain — these are usually mild. The ones that need a call to your doctor are more serious: feeling faint or actu...
📖 Read our full Valsartan guide →

🕸️ Concept Web — How Valsartan 160 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Valsartan 160 MG Oral Tablet RxCUI 349201

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Valsartan 69749
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Diovan 216652
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Valsartan Oral Tablet 378276
    • Valsartan Oral Product 1163997
    • Valsartan Pill 1164561
    • Valsartan Oral Tablet [Diovan] 368070
    • Diovan Oral Product 1171720
    • Diovan Pill 1171721
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Valsartan 160 MG SCDC · 316881
  • Valsartan Oral Tablet SCDF · 378276
  • Valsartan Oral Product SCDG · 1163997
  • Valsartan Pill SCDG · 1164561

Brand-Name Concepts

  • Valsartan 160 MG Oral Tablet [Diovan] SBD · 351762
  • Valsartan 160 MG [Diovan] SBDC · 565167
  • Valsartan Oral Tablet [Diovan] SBDF · 368070
  • Diovan Oral Product SBDG · 1171720
  • Diovan Pill SBDG · 1171721
  • Diovan BN · 216652

📦 FDA Products & Package NDCs

111 products · 312 package NDCs
312 package NDCs map to RxCUI 349201 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
76483-0025-03 90 TABLET in 1 BOTTLE (76483-025-03) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0025-04 100 TABLET in 1 BOTTLE (76483-025-04) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0025-05 500 TABLET in 1 BOTTLE (76483-025-05) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0025-06 1000 TABLET in 1 BOTTLE (76483-025-06) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0026-00 30 TABLET in 1 BOTTLE (76483-026-00) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0026-03 90 TABLET in 1 BOTTLE (76483-026-03) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0026-04 100 TABLET in 1 BOTTLE (76483-026-04) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0026-05 500 TABLET in 1 BOTTLE (76483-026-05) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
76483-0026-06 1000 TABLET in 1 BOTTLE (76483-026-06) Valsartan SQUARE PHARMACEUTICALS LIMITED 2022-07-15
82804-0154-30 30 TABLET, FILM COATED in 1 BOTTLE (82804-154-30) Valsartan Proficient Rx LP 2025-02-18
82804-0154-90 90 TABLET, FILM COATED in 1 BOTTLE (82804-154-90) Valsartan Proficient Rx LP 2024-10-03
82868-0011-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82868-011-30) Valsartan Northwind Health Company, LLC 2023-09-05
Observed labelers: Camber Pharmaceuticals, Inc. (40) · Dr. Reddy's Laboratories Limited (22) · SQUARE PHARMACEUTICALS LIMITED (20) · Alembic Pharmaceuticals Inc. (19) · Alembic Pharmaceuticals Limited (19) · Jubilant Cadista Pharmacuticals Inc. (16) · +23 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.